img

Global Adgre1 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Adgre1 Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

ADGRE1 (Adhesion G Protein-Coupled Receptor E1) is a Protein Coding gene. Among its related pathways are GPCR downstream signalling and Class A/1 (Rhodopsin-like receptors). Gene Ontology (GO) annotations related to this gene include G protein-coupled receptor activity and transmembrane signaling receptor activity. An important paralog of this gene is ADGRE2.
Adgre1 report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Adgre1 market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Biopharmaceutical Companies and Bioscience Research Institutions are the major drivers for the industry.
In terms of regions, North America is expected to remain the largest market for Adgre1 during the forecast period.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Adgre1 market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Bio-Rad
Thermo Fisher Scientific
R&D Systems
Lifespan Biosciences
Genetex
Atlas Antibodies
Abbexa Ltd
BioLegend
Segment by Type
Above 90%
Above 95%
Above 99%
Others

Segment by Application


Biopharmaceutical Companies
Bioscience Research Institutions
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Adgre1 market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Adgre1 introduction, etc. Adgre1 Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Adgre1 market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.

Table of Content

1 Market Overview of Adgre1
1.1 Adgre1 Market Overview
1.1.1 Adgre1 Product Scope
1.1.2 Adgre1 Market Status and Outlook
1.2 Global Adgre1 Market Size Overview by Region 2018 VS 2022 VS 2033
1.3 Global Adgre1 Market Size by Region (2018-2033)
1.4 Global Adgre1 Historic Market Size by Region (2018-2023)
1.5 Global Adgre1 Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Adgre1 Market Size (2018-2033)
1.6.1 North America Adgre1 Market Size (2018-2033)
1.6.2 Europe Adgre1 Market Size (2018-2033)
1.6.3 Asia-Pacific Adgre1 Market Size (2018-2033)
1.6.4 Latin America Adgre1 Market Size (2018-2033)
1.6.5 Middle East & Africa Adgre1 Market Size (2018-2033)
2 Adgre1 Market by Type
2.1 Introduction
2.1.1 Above 90%
2.1.2 Above 95%
2.1.3 Above 99%
2.1.4 Others
2.2 Global Adgre1 Market Size by Type: 2018 VS 2022 VS 2033
2.2.1 Global Adgre1 Historic Market Size by Type (2018-2023)
2.2.2 Global Adgre1 Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Adgre1 Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Adgre1 Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Adgre1 Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Adgre1 Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Adgre1 Revenue Breakdown by Type (2018-2033)
3 Adgre1 Market Overview by Application
3.1 Introduction
3.1.1 Biopharmaceutical Companies
3.1.2 Bioscience Research Institutions
3.1.3 Others
3.2 Global Adgre1 Market Size by Application: 2018 VS 2022 VS 2033
3.2.1 Global Adgre1 Historic Market Size by Application (2018-2023)
3.2.2 Global Adgre1 Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Adgre1 Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Adgre1 Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Adgre1 Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Adgre1 Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Adgre1 Revenue Breakdown by Application (2018-2033)
4 Adgre1 Competition Analysis by Players
4.1 Global Adgre1 Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adgre1 as of 2022)
4.3 Date of Key Players Enter into Adgre1 Market
4.4 Global Top Players Adgre1 Headquarters and Area Served
4.5 Key Players Adgre1 Product Solution and Service
4.6 Competitive Status
4.6.1 Adgre1 Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bio-Rad
5.1.1 Bio-Rad Profile
5.1.2 Bio-Rad Main Business
5.1.3 Bio-Rad Adgre1 Products, Services and Solutions
5.1.4 Bio-Rad Adgre1 Revenue (US$ Million) & (2018-2023)
5.1.5 Bio-Rad Recent Developments
5.2 Thermo Fisher Scientific
5.2.1 Thermo Fisher Scientific Profile
5.2.2 Thermo Fisher Scientific Main Business
5.2.3 Thermo Fisher Scientific Adgre1 Products, Services and Solutions
5.2.4 Thermo Fisher Scientific Adgre1 Revenue (US$ Million) & (2018-2023)
5.2.5 Thermo Fisher Scientific Recent Developments
5.3 R&D Systems
5.3.1 R&D Systems Profile
5.3.2 R&D Systems Main Business
5.3.3 R&D Systems Adgre1 Products, Services and Solutions
5.3.4 R&D Systems Adgre1 Revenue (US$ Million) & (2018-2023)
5.3.5 Lifespan Biosciences Recent Developments
5.4 Lifespan Biosciences
5.4.1 Lifespan Biosciences Profile
5.4.2 Lifespan Biosciences Main Business
5.4.3 Lifespan Biosciences Adgre1 Products, Services and Solutions
5.4.4 Lifespan Biosciences Adgre1 Revenue (US$ Million) & (2018-2023)
5.4.5 Lifespan Biosciences Recent Developments
5.5 Genetex
5.5.1 Genetex Profile
5.5.2 Genetex Main Business
5.5.3 Genetex Adgre1 Products, Services and Solutions
5.5.4 Genetex Adgre1 Revenue (US$ Million) & (2018-2023)
5.5.5 Genetex Recent Developments
5.6 Atlas Antibodies
5.6.1 Atlas Antibodies Profile
5.6.2 Atlas Antibodies Main Business
5.6.3 Atlas Antibodies Adgre1 Products, Services and Solutions
5.6.4 Atlas Antibodies Adgre1 Revenue (US$ Million) & (2018-2023)
5.6.5 Atlas Antibodies Recent Developments
5.7 Abbexa Ltd
5.7.1 Abbexa Ltd Profile
5.7.2 Abbexa Ltd Main Business
5.7.3 Abbexa Ltd Adgre1 Products, Services and Solutions
5.7.4 Abbexa Ltd Adgre1 Revenue (US$ Million) & (2018-2023)
5.7.5 Abbexa Ltd Recent Developments
5.8 BioLegend
5.8.1 BioLegend Profile
5.8.2 BioLegend Main Business
5.8.3 BioLegend Adgre1 Products, Services and Solutions
5.8.4 BioLegend Adgre1 Revenue (US$ Million) & (2018-2023)
5.8.5 BioLegend Recent Developments
6 North America
6.1 North America Adgre1 Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Adgre1 Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Adgre1 Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Adgre1 Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Adgre1 Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Adgre1 Market Dynamics
11.1 Adgre1 Industry Trends
11.2 Adgre1 Market Drivers
11.3 Adgre1 Market Challenges
11.4 Adgre1 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Adgre1 Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2033
Table 2. Global Adgre1 Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Adgre1 Market Size Share by Region (2018-2023)
Table 4. Global Adgre1 Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Adgre1 Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Adgre1 Market Size (US$ Million) by Type: 2018 VS 2022 VS 2033
Table 7. Global Adgre1 Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Adgre1 Revenue Market Share by Type (2018-2023)
Table 9. Global Adgre1 Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Adgre1 Revenue Market Share by Type (2024-2033)
Table 11. North America Adgre1 Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Adgre1 Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Adgre1 Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Adgre1 Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Adgre1 Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Adgre1 Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Adgre1 Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Adgre1 Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Adgre1 Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Adgre1 Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Adgre1 Market Size (US$ Million) by Application: 2018 VS 2022 VS 2033
Table 22. Global Adgre1 Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Adgre1 Revenue Market Share by Application (2018-2023)
Table 24. Global Adgre1 Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Adgre1 Revenue Market Share by Application (2024-2033)
Table 26. North America Adgre1 Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Adgre1 Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Adgre1 Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Adgre1 Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Adgre1 Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Adgre1 Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Adgre1 Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Adgre1 Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Adgre1 Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Adgre1 Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Adgre1 Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Adgre1 Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Adgre1 as of 2022)
Table 39. Date of Key Players Enter into Adgre1 Market
Table 40. Global Adgre1 Key Players Headquarters and Area Served
Table 41. Adgre1 Product Solution and Service
Table 42. Global Adgre1 Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Bio-Rad Basic Information List
Table 45. Bio-Rad Description and Business Overview
Table 46. Bio-Rad Adgre1 Products, Services and Solutions
Table 47. Revenue (US$ Million) in Adgre1 Business of Bio-Rad (2018-2023)
Table 48. Bio-Rad Recent Developments
Table 49. Thermo Fisher Scientific Basic Information List
Table 50. Thermo Fisher Scientific Description and Business Overview
Table 51. Thermo Fisher Scientific Adgre1 Products, Services and Solutions
Table 52. Revenue (US$ Million) in Adgre1 Business of Thermo Fisher Scientific (2018-2023)
Table 53. Thermo Fisher Scientific Recent Developments
Table 54. R&D Systems Basic Information List
Table 55. R&D Systems Description and Business Overview
Table 56. R&D Systems Adgre1 Products, Services and Solutions
Table 57. Revenue (US$ Million) in Adgre1 Business of R&D Systems (2018-2023)
Table 58. R&D Systems Recent Developments
Table 59. Lifespan Biosciences Basic Information List
Table 60. Lifespan Biosciences Description and Business Overview
Table 61. Lifespan Biosciences Adgre1 Products, Services and Solutions
Table 62. Revenue (US$ Million) in Adgre1 Business of Lifespan Biosciences (2018-2023)
Table 63. Lifespan Biosciences Recent Developments
Table 64. Genetex Basic Information List
Table 65. Genetex Description and Business Overview
Table 66. Genetex Adgre1 Products, Services and Solutions
Table 67. Revenue (US$ Million) in Adgre1 Business of Genetex (2018-2023)
Table 68. Genetex Recent Developments
Table 69. Atlas Antibodies Basic Information List
Table 70. Atlas Antibodies Description and Business Overview
Table 71. Atlas Antibodies Adgre1 Products, Services and Solutions
Table 72. Revenue (US$ Million) in Adgre1 Business of Atlas Antibodies (2018-2023)
Table 73. Atlas Antibodies Recent Developments
Table 74. Abbexa Ltd Basic Information List
Table 75. Abbexa Ltd Description and Business Overview
Table 76. Abbexa Ltd Adgre1 Products, Services and Solutions
Table 77. Revenue (US$ Million) in Adgre1 Business of Abbexa Ltd (2018-2023)
Table 78. Abbexa Ltd Recent Developments
Table 79. BioLegend Basic Information List
Table 80. BioLegend Description and Business Overview
Table 81. BioLegend Adgre1 Products, Services and Solutions
Table 82. Revenue (US$ Million) in Adgre1 Business of BioLegend (2018-2023)
Table 83. BioLegend Recent Developments
Table 84. North America Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific Adgre1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 89. Asia-Pacific Adgre1 Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Adgre1 Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Adgre1 Market Share by Region (2018-2023)
Table 92. Asia-Pacific Adgre1 Market Share by Region (2024-2033)
Table 93. Latin America Adgre1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 94. Latin America Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa Adgre1 Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 97. Middle East & Africa Adgre1 Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Adgre1 Market Size by Country (2024-2033) & (US$ Million)
Table 99. Adgre1 Market Trends
Table 100. Adgre1 Market Drivers
Table 101. Adgre1 Market Challenges
Table 102. Adgre1 Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adgre1 Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Adgre1 Market Size (US$ Million), 2018 VS 2022 VS 2033
Figure 3. Global Adgre1 Market Share by Regions: 2022 VS 2033
Figure 4. Global Adgre1 Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Adgre1 Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Adgre1 Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Adgre1 Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Adgre1 Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Adgre1 Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Above 90%
Figure 11. Global Above 90% Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Above 95%
Figure 13. Global Above 95% Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Above 99%
Figure 15. Global Above 99% Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 18. Global Adgre1 Market Size Share by Type: 2022 & 2033
Figure 19. North America Adgre1 Revenue Market Share by Type (2018-2033)
Figure 20. Europe Adgre1 Revenue Market Share by Type (2018-2033)
Figure 21. Asia-Pacific Adgre1 Revenue Market Share by Type (2018-2033)
Figure 22. Latin America Adgre1 Revenue Market Share by Type (2018-2033)
Figure 23. Middle East and Africa Adgre1 Revenue Market Share by Type (2018-2033)
Figure 24. Biopharmaceutical Companies Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Bioscience Research Institutions Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Others Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 27. Global Adgre1 Market Size Share by Application: 2022 & 2033
Figure 28. North America Adgre1 Revenue Market Share by Application (2018-2033)
Figure 29. Europe Adgre1 Revenue Market Share by Application (2018-2033)
Figure 30. Asia-Pacific Adgre1 Revenue Market Share by Application (2018-2033)
Figure 31. Latin America Adgre1 Revenue Market Share by Application (2018-2033)
Figure 32. Middle East and Africa Adgre1 Revenue Market Share by Application (2018-2033)
Figure 33. Adgre1 Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 34. Global Top 5 and Top 10 Players Adgre1 Market Share in 2022
Figure 35. North America Adgre1 Market Share by Country (2018-2033)
Figure 36. U.S. Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 37. Canada Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 38. Germany Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 39. France Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 40. U.K. Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 41. Italy Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 42. Russia Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 43. Nordic Countries Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 44. Asia-Pacific Adgre1 Market Share by Region (2018-2033)
Figure 45. China Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 46. Japan Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 47. South Korea Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 48. Southeast Asia Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 49. India Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 50. Australia Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 51. Latin America Adgre1 Market Share by Country (2018-2033)
Figure 52. Mexico Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 53. Brazil Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 54. Middle East & Africa Adgre1 Market Share by Country (2018-2033)
Figure 55. Turkey Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 57. UAE Adgre1 Market Size (2018-2033) & (US$ Million)
Figure 58. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries